Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study von Crinò, Lucio, Prof, Dansin, Eric, MD, Garrido, Pilar, MD, Griesinger, Frank, Prof, Laskin, Janessa, MD, Pavlakis, Nick, MBBS, Stroiakovski, Daniel, Prof, Thatcher, Nick, Prof, Tsai, Chun-Ming, Prof, Wu, Yi-long, Prof, Zhou, Caicun, Prof

Volltext

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an o... von Thatcher, Nick, Prof, Hirsch, Fred R, Prof, Luft, Alexander V, MD, Szczesna, Aleksandra, MD, Ciuleanu, Tudor E, Prof, Dediu, Mircea, MD, Ramlau, Rodryg, Prof, Galiulin, Rinat K, MD, Bálint, Beatrix, MD, Losonczy, György, Prof, Kazarnowicz, Andrzej, MD, Park, Keunchil, MD, Schumann, Christian, Prof, Reck, Martin, MD, Depenbrock, Henrik, MD, Nanda, Shivani, MS, Kruljac-Letunic, Anamarija, PhD, Kurek, Raffael, MD, Paz-Ares, Luis, MD, Socinski, Mark A, Prof

Volltext

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial von Butts, Charles, Dr, Socinski, Mark A, Prof, Mitchell, Paul L, MD, Thatcher, Nick, Prof, Havel, Libor, MD, Krzakowski, Maciej, Prof, Nawrocki, Sergiusz, MD, Ciuleanu, Tudor-Eliade, MD, Bosquée, Lionel, MD, Trigo, José Manuel, MD, Spira, Alexander, MD, Tremblay, Lise, MD, Nyman, Jan, MD, Ramlau, Rodryg, MD, Wickart-Johansson, Gun, MD, Ellis, Peter, MD, Gladkov, Oleg, MD, Pereira, José Rodrigues, MD, Eberhardt, Wilfried Ernst Erich, MD, Helwig, Christoph, Dipl Stat, Schröder, Andreas, MD, Shepherd, Frances A, Prof

Volltext

Clinicopathologic Features of Advanced Squamous NSCLC von Socinski, Mark A., Obasaju, Coleman, Gandara, David, Hirsch, Fred R., Bonomi, Philip, Bunn, Paul, Kim, Edward S., Langer, Corey J., Natale, Ronald B., Novello, Silvia, Paz-Ares, Luis, Pérol, Maurice, Reck, Martin, Ramalingam, Suresh S., Reynolds, Craig H., Spigel, David R., Stinchcombe, Thomas E., Wakelee, Heather, Mayo, Carlos, Thatcher, Nick

Volltext

Molecular Predictors of Outcome With Gefitinib in a Phase III Placebo-Controlled Study in Advanced Non–Small-Cell Lung Cancer von HIRSCH, Fred R, VARELLA-GARCIA, Marileila, VON PAWEL, Joachim, WATKINS, Claire, FLANNERY, Angela, ELLISON, Gillian, DONALD, Emma, KNIGHT, Lucy, PARUMS, Dinah, BOTWOOD, Nicholas, HOLLOWAY, Brian, BUNN, Paul A, FRANKLIN, Wilbur A, DZIADZIUSZKO, Rafal, THATCHER, Nick, CHANG, Alex, PARIKH, Purvish, PEREIRA, José Rodrigues, CIULEANU, Tudor

Volltext

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled p... von Paz-Ares, Luis, Dr, Mezger, Jörg, Prof, Ciuleanu, Tudor E, Prof, Fischer, Jürgen R, MD, von Pawel, Joachim, MD, Provencio, Mariano, Prof, Kazarnowicz, Andrzej, MD, Losonczy, György, Prof, de Castro, Gilberto, MD, Szczesna, Aleksandra, MD, Crino, Lucio, MD, Reck, Martin, MD, Ramlau, Rodryg, Prof, Ulsperger, Ernst, MD, Schumann, Christian, MD, Miziara, Jose Elias A, MD, Lessa, Álvaro E, MD, Dediu, Mircea, MD, Bálint, Beatrix, PhD, Depenbrock, Henrik, MD, Soldatenkova, Victoria, MSc, Kurek, Raffael, MD, Hirsch, Fred R, Prof, Thatcher, Nick, FRCP, Socinski, Mark A, Prof

Volltext

Vaccines for the treatment of non-small cell lung cancer: Investigational approaches and clinical experience von Mellstedt, Håkan, Vansteenkiste, Johan, Thatcher, Nick

Volltext

ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug development von Scagliotti, Giorgio, Stahel, Rolf A, Rosell, Rafael, Thatcher, Nick, Soria, Jean-Charles

Volltext

Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer von SOCINSKI, Mark A, SMIT, Egbert F, JASSEM, Jacek, DEDIU, Mircea, SHENGYAN HONG, VISSEREN-GRUL, Carla, HANAUSKE, Axel-Rainer, OBASAJU, Coleman K, GUBA, Susan C, THATCHER, Nick, LORIGAN, Paul, KONDURI, Kartik, RECK, Martin, SZCZESNA, Aleksandra, BLAKELY, Johnetta, SERWATOWSKI, Piotr, KARASEVA, Nina A, CIULEANU, Tudor

Volltext

Epidermal Growth Factor Receptor Inhibition in Lung Cancer: Status 2012 von Hirsch, Fred R., Jänne, Pasi A., Eberhardt, Wilfried E., Cappuzzo, Federico, Thatcher, Nick, Pirker, Robert, Choy, Hak, Kim, Edward S., Paz-Ares, Luis, Gandara, David R., Wu, Yi-Long, Ahn, Myung-Ju, Mitsudomi, Tetsuya, Shepherd, Frances A., Mok, Tony S.

Volltext

Meta-analysis of individual patient data from randomized trials of chemotherapy plus cetuximab as first-line treatment for advanced non-small cell lung cancer von Pujol, Jean-Louis, Pirker, Robert, Lynch, Thomas J, Butts, Charles A, Rosell, Rafael, Shepherd, Frances A, Vansteenkiste, Johan, O’Byrne, Kenneth J, de Blas, Barbara, Heighway, Jim, von Heydebreck, Anja, Thatcher, Nick

Volltext

Erlotinib for Frontline Treatment of Advanced Non–Small Cell Lung Cancer: a Phase II Study von Giaccone, Giuseppe, Gallegos Ruiz, Marielle, Le Chevalier, Thierry, Thatcher, Nick, Smit, Egbert, Rodriguez, Jose Antonio, Janne, Pasi, Oulid-Aissa, Dalila, Soria, Jean-Charles

Volltext

EGFR Gene Copy Number by FISH May Predict Outcome of Necitumumab in Squamous Lung Carcinomas: Analysis from the SQUIRE Study von Genova, Carlo, Socinski, Mark A., Hozak, Rebecca R., Mi, Gu, Kurek, Raffael, Shahidi, Javad, Paz-Ares, Luis, Thatcher, Nick, Rivard, Christopher J., Varella- Garcia, Marileila, Hirsch, Fred R.

Volltext

Lung cancer after treatment for breast cancer von Lorigan, Paul, Dr, Califano, Raffaele, MD, Faivre-Finn, Corinne, PhD, Howell, Anthony, Prof, Thatcher, Nick, Prof

Volltext

Lung cancer after treatment for Hodgkin's lymphoma: a systematic review von Lorigan, Paul, Radford, John, Howell, Anthony, Thatcher, Nick

Volltext

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies von Hirsch, Fred R., Kerr, Keith M., Bunn, Paul A., Kim, Edward S., Obasaju, Coleman, Pérol, Maurice, Bonomi, Philip, Bradley, Jeffrey D., Gandara, David, Jett, James R., Langer, Corey J., Natale, Ronald B., Novello, Silvia, Paz-Ares, Luis, Ramalingam, Suresh S., Reck, Martin, Reynolds, Craig H., Smit, Egbert F., Socinski, Mark A., Spigel, David R., Stinchcombe, Thomas E., Vansteenkiste, Johan F., Wakelee, Heather, Thatcher, Nick

Volltext

Second-Line Treatment of Advanced Non-small Cell Lung Cancer von Gridelli, Cesare, Ardizzoni, Andrea, Ciardiello, Fortunato, Hanna, Nasser, Heymach, John V., Perrone, Francesco, Rosell, Rafael, Shepherd, Frances A., Thatcher, Nick, Vansteenkiste, Johan, De Petris, Luigi, Di Maio, Massimo, De Marinis, Filippo

Volltext

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer von Eisen, Tim, Thatcher, Nick, Leyvraz, Serge, Miller, Wilson H, Couture, Felix, Lorigan, Paul, Lüthi, François, Small, David, Tanovic, Adnan, O’Brien, Mary

Volltext

START: A phase III study of L-BLP25 cancer immunotherapy for unresectable stage III non-small cell lung cancer von Butts, Charles Andrew, Socinski, Mark A., Mitchell, Paul, Thatcher, Nick, Havel, Libor, Krzakowski, Maciej Jerzy, Nawrocki, Sergiusz, Ciuleanu, Tudor-Eliade, Bosquée, Lionel, Trigo Perez, Jose Manuel, Spira, Alexander I., Tremblay, Lise, Nyman, Jan, Ramlau, Rodryg, Helwig, Christoph, Falk, Martin H., Shepherd, Frances A.

Volltext

Where next for gefitinib in patients with lung cancer? von Blackhall, Fiona, Ranson, Malcolm, Thatcher, Nick

Volltext